Molecular Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2021-04-17 ms7000002126254802

偏重的研究方向： Cancer ; lncRNA ; 血管新生
经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦

85 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2021-09-07 小窝头儿

朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗

94 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2021-10-09 打死不发文章

审稿速度:3.0 | 投稿命中率:75.0
经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢

64 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2024-01-10 1464d723m79暂无昵称来自广东省

Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？

38 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2024-01-08 P拾荒者来自浙江省

偏重的研究方向：肿瘤生物学
经验分享：1.7投了一篇综述，看看多久拒稿

28 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2020-05-31 zoom

一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿

141 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2022-03-01 Crazy007

发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。

116 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2021-07-20 牧与歌

杂志回复说额外寻找统计师进行审稿，代表什么呢？

44 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2020-10-11 1561f3561fm

editor invited 已经20天了，有人经历过这个状态吗？

159 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=957872, encodeId=af2195e87211, content=偏重的研究方向： Cancer ; lncRNA ; 血管新生 经验分享：edito r assigned都6天啦，编辑怎么还不送外审哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff45338182, createdName=ms7000002126254802, createdTime=Sat Apr 17 18:17:46 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015330, encodeId=414f101533037, content=朋友们，就想知道什么时候拒稿呀，怎么快15天了，还是editor invited，，这是没有编辑愿意审稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10c72315100, createdName=小窝头儿, createdTime=Tue Sep 07 11:21:32 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058799, encodeId=1e3f1058e9968, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：请问一下大家，proof版本如何给编辑部，大家都是写信嘛，网上从哪里能找到online连接呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/90572e1acf2045108370a7cec3b01d93/50a98abcc9c944e38928a81ac399ebfe.jpg, createdBy=3b3d5503701, createdName=打死不发文章, createdTime=Sat Oct 09 08:19:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了，大家有遇到这种情况吗，是稿件太多了处理不过来吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向：肿瘤生物学 经验分享：1.7投了一篇综述，看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=600955, encodeId=d40d600955d6, content=一审3个月，二审3个月还在editor assigned，除开修回时间，待在审稿和杂志社的时间超半年，谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be402419767, createdName=zoom, createdTime=Sun May 31 15:46:44 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198256, encodeId=2e8e119825671, content=发不出molecular cancer的人在这dis发了molecular cancer的人。也是悲哀。有些人：目标cancer discovery就不要作为你的网络名字了，…发不出来丢人的，事没成，搞的好像你一定能发出来一样。估计发不出文章造成了某些人极端与偏执的性格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200902/e8995f4d9193498583eeec90b8ca200b/f68e8fa6660948eba29580a7c92fa634.jpg, createdBy=de425415079, createdName=Crazy007, createdTime=Tue Mar 01 07:56:03 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001209, encodeId=a9701001209d0, content=杂志回复说额外寻找统计师进行审稿，代表什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItnUSB5w846Cw3KdSjfz2ibEoykJSB1ib5Uez8ibY6d8SDmIWPibUmdfpTiaLmiaOkKS5Al3MVdKu3mBSQ/132, createdBy=59555149277, createdName=牧与歌, createdTime=Tue Jul 20 18:54:50 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891189, encodeId=fa3d8911897e, content=editor invited 已经20天了，有人经历过这个状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7402086556, createdName=1561f3561fm, createdTime=Sun Oct 11 01:05:52 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905174, encodeId=09e09051e475, content=1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=刘wings, createdTime=Sat Dec 05 13:12:20 CST 2020, time=2020-12-05, status=1, ipAttribution=)]

2020-12-05 刘wings

1/2的综述，70%的国人发文量，很危险。据说在大项目申报时有一票否决权

214 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务